Publication supports Topas’ approach to generating immune tolerance through in vivo autoimmune disease model data in type 1 diabetes and multiple sclerosis Topas’ platform leverages the capability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback